Company news
PharmaCielo Ltd. news in 2019
PharmaCielo Ltd.'s news releases, calls and decks from 2019, newest first.
PharmaCielo Awarded Game-Changer Award by MJDaily
December 14, 2019
PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
December 5, 2019
PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility
December 2, 2019
PharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019
November 25, 2019
PharmaCielo Announces RSU Grant
November 8, 2019
PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma
November 5, 2019
PharmaCielo Trading Halted Pending Update from Creso Pharma
November 4, 2019
PharmaCielo Provides Update on Proposed Acquisition of Creso Pharma
November 1, 2019
PharmaCielo Announces Creso Pharma's Receipt of Australian Court Approval to Convene Meeting of Shareholders
October 2, 2019
PharmaCielo Enters the U.S. with $3 Million Q4 Sales Agreement and Completes Introductory Shipments to Multi-state Distributor General Extract LLC
September 25, 2019
PharmaCielo Announces Financial Results for the Second Quarter 2019
August 27, 2019
PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe
August 19, 2019
PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler
August 13, 2019
PharmaCielo Joins Canadian Market Cannabis Tracking and Verification Initiative
August 8, 2019
PharmaCielo Colombia Holdings S.A.S. Appoints New and Diversified Board of Directors
August 2, 2019
PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts
August 1, 2019
PharmaCielo Completes Acquisition of Ubiquo Telemedicina
July 26, 2019
PharmaCielo First to Receive Colombian Government Export Approval for Commercial Sale of CBD Isolate
July 25, 2019
PharmaCielo Colombia Holdings S.A.S. Appoints Andres Felipe Botero as Chief Operations Officer
July 22, 2019
PharmaCielo Announces Trading on the OTC Market
June 21, 2019
PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
June 6, 2019
PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor
May 29, 2019
PharmaCielo Announces its Financial Results for the First Quarter 2019
May 27, 2019
PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018
April 18, 2019
PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board
April 9, 2019
PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration
March 29, 2019
PharmaCielo Receives ISO 9001 Quality Assurance Certification for its Medicinal Cannabis Cultivation and Processing Operations in Colombia
March 19, 2019
Top 3 Cannabis Stocks Higher on Colombian Growth Story
February 14, 2019
PharmaCielo Receives Approval for Cultivar Registration of 10 Proprietary Cannabis Strains
February 6, 2019
PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
January 28, 2019
PharmaCielo Ltd. Opens the Market
January 18, 2019
PharmaCielo Begins Trading on the TSX Venture Exchange Under Ticker PCLO
January 18, 2019
Decks in 2019
- Investor Presentation (February 2019)
Investor deck · 23 slides · February 2019
- Investor Presentation (January 2019)
Investor deck · 21 slides · January 2019